Press "Enter" to skip to content

New patent for Exeltis Usa drug DROSPIRENONE

0
Copyright © DrugPatentWatch. Originally published at New patent for Exeltis Usa drug DROSPIRENONE

Annual Drug Patent Expirations for DROSPIRENONE
Annual Drug Patent Expirations for DROSPIRENONE

Drospirenone is a drug marketed by Exeltis Usa Inc, Barr, Glenmark Pharms Ltd, Hetero Labs Ltd, Hlthcare, Jubilant Cadista, Mylan Labs Ltd, Watson Labs, Apotex, Lupin Ltd, Mayne Pharma, Naari Pte Ltd, and Watson Labs Inc and, and is included in twenty NDAs. There are nine patents protecting this drug.

This drug has fifty patent family members in twenty-seven countries.

The generic ingredient in DROSPIRENONE is drospirenone; ethinyl estradiol; levomefolate calcium. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Exeltis Usa drug DROSPIRENONE
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions